archive-edu.com » EDU » G » GEORGETOWN.EDU

Total: 186

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Office of Technology Commercialization | Georgetown University
    Patent Awards Ceremony 2015 Patent Awards Ceremony 2015 Patent Awards Ceremony 2015 Patent Awards Ceremony Invention to Innovation I2I Nov 6 2014 How to Maximize the Value of your IP Invention to Innovation I2I Nov 6 2014 How to Maximize the Value of Your IP National Academy of Inventors Induction Feb 25 2014 Welcome Welcome to the home page of the Office of Technology Commercialization at Georgetown University The duties of the Office of Technology Commercialization OTC include management of Georgetown invention disclosures patenting and licensing activities oversight of material transfer agreements and confidentiality agreements and engagement of Georgetown University in the founding and growth of local businesses About Us For Georgetown Inventors Reporting an invention and other resources Industry Collaboration Opportunities for Georgetown Principal Investigators UPDATED LISTINGS For Industry Technology Licensing Opportunities TOP STORIES FROM OTC Read our Recent Quarterly Newsletter the OTC Review Winter 2015 Fall 2014 New Technologies for Licensing A Novel Composition for Selective Imaging and Therapy of Cancer Ezrin Inhibitors for the Treatment of Cancer and Novel Antagonists of Angiotensin Type I Receptor to Treat Hypertension Georgetown University and Amarantus Bioscience Holdings Sign Exclusive Option Agreement Jan 15 2015 NPR Article on Dr Richard Schlegel s work on cervical cancer treatment Jan 7 2015 NPR Article on Dr Bob Clarke s work on human cancer cell lines Dec 9 2014 FUNDING OPPORTUNITY Bill Melinda Gates Foundation Global Health Development Awards Georgetown Biology professor named D C Professor of the Year Georgetown News Researcher Debunks Alzheimer s Prevailing Development Theory Georgetown Research News Investigators check out Industry Collaboration Opportunities HERE Our Suggestion Box is now live We invite the Georgetown community to share feedback on any aspect of OTC s activities Georgetown Inventors Howard Federoff and Massimo Fiandaca Featured for New Technology Predicting Alzheimer s and

    Original URL path: http://otc.georgetown.edu/ (2015-07-11)
    Open archived version from archive


  • Patent Awards Ceremony 2015 | Office of Technology Commercialization | Georgetown University
    Ms Knowles was the SVP and Chief Patent Counsel at GlaxoSmithKline as worldwide head of patents for litigation and transactional matters managing over 200 people in 12 offices In 2008 Managing IP Magazine named Ms Knowles one of the top 10 most influential people in Intellectual Property referring to her as a Patent Owner s Advocate In 2010 the New Jersey IP Lawyers Association awarded GSK with Ms Knowles as the representative the Jefferson Medal for exceptional contribution to Intellectual Property In 2010 Managing IP Magazine named the GSK Global Patent Team the In House IP Team of the Year for 2009 for the constructive approach to IP in the developing world the engagement with public policy in Europe and the successful resolution of the USPTO rules matter in the US In November 2011 IAM Magazine listed Ms Knowles among the top fifty key individuals companies and institutions that have shaped the IP marketplace in the last eight years Ms Knowles was among IAM Magazine s 250 World s Leading IP Strategists in 2011 and IAM 300 in 2012 2013 and 2014 and Managing IP Magazine s Top 250 Women in IP in 2014 Ms Knowles has been active in IP matters in developing countries Ms Knowles helped create GSK s Knowledge Pool for treatment of neglected tropical diseases In December 2010 Ms Knowles chaired a conference at the World Bank on The Role of Intellectual Property in Development In 2011 Ms Knowles co chaired a conference in Cape Town South Africa on Accelerating Innovation and IP in South Africa and in 2013 in Durban South Africa on Creating and Leveraging IP in Developing Countries ROBERT ZIVIN PH D Pharma Academia Collaborations Avoiding the Random Walk Zivin presentation pdf Robert Zivin PhD is Senior Fellow Wallace H Coulter Center for Translational Research and Research Associate Professor Medicine His role at the University of Miami is to facilitate the development of new approaches and technologies for improving healthcare Specifically working with faculty to help define unmet needs likely commercial partners and the lowest commercializable unit Previously Dr Zivin was Senior Director in Johnson Johnson s Corporate Office of Science Technology COSAT He has spent 33 years in Healthcare R D 26 at J J working in biotechnology molecular diagnostics and drug discovery and holds numerous patents His work has led to numerous clinical trials and an FDA approved therapeutic During his 9 years at COSAT Dr Zivin worked on the development of new models of collaboration with the twin aims of facilitating academic partnering and shifting the cost reward profile of product development This approach recognized the high risk adjusted cost of in house basic research and the benefits to be gained by providing academic partners with access to skilled pharmaceutical scientists and associated technologies Dr Zivin received his PhD from the University of Chicago and did a post doctoral fellowship at the National Cancer Institute He has served on a number of scientific advisory and grant selection committees KIRAN REDDY

    Original URL path: https://otc.georgetown.edu/pac2015 (2015-07-11)
    Open archived version from archive

  • About Us | Office of Technology Commercialization | Georgetown University
    Georgetown University Office of Technology Commercialization OTC was instituted in 2002 to underscore the University s commitment to protecting the intellectual property and interests of Georgetown researchers and to strongly engage Georgetown in the economic development of the Washington DC metropolitan area Location Office of Technology Commercialization Georgetown University Harris Building Suite 1500 3300 Whitehaven St NW Washington DC 20007 United States Getting to Our Office The Harris Building pictured below of Georgetown University is located off campus and accessible by the Georgetown University Transportation Shuttle GUTS Wisconsin Avenue line schedule which stops at Darnall Hall in front of the Epicurean restaurant on the Main Campus The Harris Building is located opposite the Holiday Inn and British School of Washington Non Georgetown persons are required to present an official ID to board the GUTS shuttle The Office is also accessible via the Circulator Georgetown and the 31 32 and 36 bus lines that stops at 35th St NW and Wisconsin Ave NW in front of the Safeway British School of Washington Phone 1 202 687 7424 Fax 1 202 687 3111 Email techlicensing at georgetown dot edu Social Media Twitter Facebook Office Hours Monday through Friday 8 30AM EST to

    Original URL path: http://otc.georgetown.edu/about (2015-07-11)
    Open archived version from archive

  • For Inventors at Georgetown | Office of Technology Commercialization | Georgetown University
    your invention in paper format in the link below or request a copy via email If you believe that you have an invention it is critical that you disclose the invention to the Office immediately In some cases an inventor can lose the right to a patent by failing to take the necessary measures to prevent the invention from entering into the public domain Therefore before you present your data at a meeting submit a manuscript or address a seminar or symposium fill out an invention disclosure form obtain the appropriate signatures and return it to the Office We highly encourage you to submit your disclosure online for easier input editing and review OTC will review and process your invention disclosure per its normal procedures but this format should allow for faster entry into our process We hope this will be the first step in granting access to the evaluation of your invention and to possible subsequent patent protection and prosecution proceedings Prior to login please read the following important terms of use 1 Guidelines to Inventions 2 Georgetown University s Intellectual Property Policy 3 Confidential Information Acknowledgement read the below paragraph When you use this website you may be presented with information and materials of a confidential and or proprietary nature Confidential Information The Confidential Information contained on this inventor accessible website may include but is not necessarily limited to unpublished patent applications and other materials that are not available to the public By entering this website you agree to hold all Confidential Information in confidence and not to disclose such Confidential Information to any person or entity without the permission of the Office of Technology Commercialization OTC If you have any questions regarding whether any of the information on this website is Confidential Information please contact OTC at

    Original URL path: http://otc.georgetown.edu/inventors (2015-07-11)
    Open archived version from archive

  • Licensing Opportunities | Office of Technology Commercialization | Georgetown University
    Small Molecular Weight Myc max Inhibitors Small molecule inhibitors of the tubulin carboxy peptidase AGBL2 Strigolactones A Novel Class of Phytohormones that Inhibit the Growth and Survival of Breast Cancer Cells Voltage Gated Sodium Channel Blockers as Treatment for Prostate Cancer Neurodegenerative Therapeutics 10 Substituted Cytisine Derivatives and Methods of Use Thereof A Novel Method for Predicting Drug Target Interactions and Its Uses for Drug Repositioning ALK as the Therapeutic Target for the Treatment of Proliferative Vascular and Neurological Disorders Induced by Pleiotrophin Combination of Huperzine and Nicotinic Compounds as a Neuroprotective Agent Histone Deacetylase HDAC Inhibitors Ligands for Nicotinic Acetylcholine Receptors and Methods of Making and Using Them Radioprotector Compounds Treating Neurodegenerative Disease by Regulating Parkin Diagnostics A Fast Quantitative Mass Spectrometric Analysis for 1 25 dihydroxyvitamin D3 A Novel and Non Invasive fMRI Biomarker of Neurodegenerative Disease A Novel Composition for Selective Imaging and Therapy of Cancer ALK as the Therapeutic Target for the Treatment of Proliferative Vascular and Neurological Disorders Induced by Pleiotrophin Anti Pleiotrophin Neutralizing Antibodies for the Treatment of Cancer Biomarkers for Diagnosis and Prognosis of Thyroid Cancer Dosimetry System Based on Optically Stimulated Luminesence Fluorescent CDK Inhibitors for the Treatment and Diagnosis of Cancer Methods and Composition for the Inhibition of Stat5 in Primary and Advanced Prostate Cancer Cells Organ homing proteins to detect and treat Metastatic Cancer STAG2 deficient Human Cell Lines to Screen Anticancer Compounds Ultrahigh Density Tissue Microarrays Viruses Chronic Infectious Diseases A Novel Method for Predicting Drug Target Interactions and Its Uses for Drug Repositioning New Antibiotics for Treating Gram Positive Bacterial Infections New Flavivirus Inhibitors for Treating Infections Such as West Nile and Dengue Novel Anti Fungal Drugs Against Infections Caused by Candida albicans Therapeutics for Giardia Lamblia Infections Respiratory Diseases A Novel Method for Predicting Drug Target Interactions and Its Uses for Drug Repositioning Treatment of Pulmonary Disorders with Retinoic Acid or Other Retinoids by Inducing Formation of Gas Exchange Units Alveoli The Use of Anthracyclines to Treat Pulmonary Hypertension Cardiovascular Diseases A Novel Method for Predicting Drug Target Interactions and Its Uses for Drug Repositioning ALK as the Therapeutic Target for the Treatment of Proliferative Vascular and Neurological Disorders Induced by Pleiotrophin Novel Antagonists of Angiotensin Type I Receptor to Treat Hypertension New Biomarkers and Targets for Diagnosis of Atherosclerotic Plaque and Collaterals Peroxisome Proliferator Activated Receptors PPARs Antagonists Plant Diseases Novel Small Molecules to Prevent Drought Induced Plant Damage A Novel Method for Predicting Drug Target Interactions and Its Uses for Drug Repositioning Research Tools A Novel and Non Invasive fMRI Biomarker of Neurodegenerative Disease ALK as the Therapeutic Target for the Treatment of Proliferative Vascular and Neurological Disorders Induced by Pleiotrophin Anti Pleiotrophin Neutralizing Antibodies for the Treatment of Cancer Biomarkers for Diagnosis and Prognosis of Thyroid Cancer B Raf Gene Targeted Human Cancer Cells for Identification and Testing of Novel Anticancer Drugs K Ras Gene Targeted Human Cancer Cells for Identification and Testing of Novel Anticancer Drugs Markers for Abnormal Cell Organ homing proteins

    Original URL path: http://otc.georgetown.edu/industry (2015-07-11)
    Open archived version from archive

  • Frequently Asked Questions (FAQs) | Office of Technology Commercialization | Georgetown University
    abandon the filing which allows the information to become public or convert the provisional application to a regular patent application What is the advantage of filing a provisional patent In addition to establishing the filing date and to being lower cost The University and inventors gain a twelve month block of time to further develop the invention acquire funding determine marketability seek licensees before having the major expense of a regular filing What does it cost to file and prosecute a patent Typically the cost of preparing filing a patent will be between 6 000 to 9 000 depending on the complexity of the application Prosecution of the application the process of shepherding the application thru various stages of the patent review process prior to issuance will increase the total cost between 13 000 to 25 000 Foreign patents can be extremely expensive often in excess of 100 000 to 150 000 from filing to issue depending on the country What is a Declaration A Declaration is an oath that the applicant makes wherein he states that he believes himself to be the original and first inventor of the process machine manufacture or composition of matter or improvement thereof for which he solicits a patent and shall state of what country he is a citizen What is Power of Attorney When a registered attorney or agent acting in a representative capacity appears in person or signs a paper in practice before the Patent and Trademark Office in a patent case his or her personal appearance or signature shall constitute a representation to the Patent and Trademark Office that under the provisions of the law he or she is authorized to represent Georgetown University What is an assignment Applications for patent patents or any interest therein shall be assignable in law by an instrument in writing An assignment is a certificate of acknowledgment under the hand and official seal of a person authorized to administer oaths within the United States or in a foreign country of a diplomatic or consular officer of the United States or an officer authorized to administer oaths whose authority is proved by a certificate of a diplomatic or consular officer of the United States or apostille of an official designated by a foreign country which by treaty or convention accords like effect to apostilles of designated officials in the United States This certificate shall be prima facie evidence of the execution of an assignment grant or conveyance of a patent or application for patent Why do I have to assign my patent to Georgetown University According to Georgetown University policy all inventions conceived and or reduced to practice at Georgetown University during a research or other assignment given to a staff member pursuant to a research project grant or contract or any other University administered program or utilizing facilities equipment funds or other contributions of the University and provided that the University has not entered into a research grant or contract agreement with express provisions to

    Original URL path: http://otc.georgetown.edu/faq (2015-07-11)
    Open archived version from archive

  • Resources | Office of Technology Commercialization | Georgetown University
    Human Resources McDonough School of Business Georgetown University Library GU Share Scientific Journals Science Nature Cell Neuron PNAS Licensing and Business Related Sites Association of University Technology Managers AUTM Chemical Abstracts Service Council on Governmental Relations Edgar Online FreeEDGAR Hoovers Online Knowledge Express Licensing Executives Society PricewaterhouseCoopers Money Tree Survey PubMed Recombinant Capital TechEx Patent Law Related Sites Delphion Intellectual Property Network iEdison Knowledge Express Pat2PDF U S Patent and

    Original URL path: http://otc.georgetown.edu/resources (2015-07-11)
    Open archived version from archive

  • Staff Directory | Office of Technology Commercialization | Georgetown University
    J D Associate Director Licensing Contracts 202 687 7629 Email Sharon E Prisco Esq Associate Director Licensing and Intellectual Property 202 687 8712 Email David Humphrey Ph D Senior Licensing Manager 202 687 2702 Email Jim Knabb Ph D Licensing Associate 202 687 0859 Email Silvana Alcocer CP IP Contracts Administrator 202 687 0843 Email Lori Fitzhugh Manager Administration Operations 202 687 2768 Email Azra Chughtai MA Executive Assistant to

    Original URL path: http://otc.georgetown.edu/staff-directory (2015-07-11)
    Open archived version from archive



  •